
1. j infect dis. 1995 jul;172(1):11-8.

use human papillomavirus type 6 capsids detect antibodies people with
genital warts.

carter jj(1), wipf gc, hagensee me, mcknight b, habel la, lee sk, kuypers j,
kiviat n, daling jr, koutsky la, et al.

author information: 
(1)fred hutchinson cancer research center, university washington, seattle,
usa.

human papillomavirus (hpv) type 6 capsids produced recombinant vaccinia
viruses used capture elisa screen 901 human sera three studies
of genital hpvs. highest seroprevalence observed among subjects with
recurrent genital warts. population-based case-control study genital
warts, 26 (58%) 45 women recurrent genital warts seropositive
compared 19 (19%) 101 control women history genital warts
(odds ratio, 6.5; 95% confidence interval, 3.0, 14.1). among cohort pregnant
women, 7 (88%) 8 recurrent warts seropositive compared 24 (30%)
of 79 pregnant women history. significant association between
seropositivity hpv-6 capsids detection hpv-6/11 dna genital
specimens polymerase chain reaction also observed. men genital warts 
were less likely seropositive women genital warts, a
positive association number sex partners seropositivity was
observed among female university students.

doi: 10.1093/infdis/172.1.11 
pmid: 7797899  [indexed medline]

